Off-Label Use of Oral Metronidazole in Dermatology | Therapeutic Cheat Sheet
157691576915769
While we have an increasing armamentarium of biologic agents and targeted systemic medications for certain dermatologic conditions such as psoriasis or atopic dermatitis, treatment options are still limited for a litany of other inflammatory cutaneous disorders. Additionally, when discussing therapeutic options, patients often opt for medications that are established, safe, well-tolerated and mini …
While we have an increasing armamentarium of biologic agents and targeted systemic medications for certain dermatologic conditions such as psoriasis or atopic dermatitis, treatment options are still limited for a litany of other inflammatory cutaneous disorders. Additionally, when discussing therapeutic options, patients often opt for medications that are established, safe, well-tolerated and mini … Continue reading "Off-Label Use of Oral Metronidazole in Dermatology | Therapeutic Cheat Sheet"
The May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk:
Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes concludes … 